Ketorolac Tromethamine Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Sagent Pharmaceuticals with status Current. The shortage was first posted on Mar 26, 2018. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- Sagent Pharmaceuticals
- Package NDC
- 25021-701-02
- Dosage Form
- Injection
- Presentation
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)
- Initial Posting
- Mar 26, 2018
Reason
Demand increase for the drug